GoodRx Holdings, Inc.
GDRX
$4.44
-$0.035-0.78%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 792.32M | 790.39M | 775.09M | 764.16M | 750.27M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 792.32M | 790.39M | 775.09M | 764.16M | 750.27M |
| Cost of Revenue | 48.22M | 46.69M | 53.73M | 58.20M | 62.43M |
| Gross Profit | 744.11M | 743.69M | 721.36M | 705.96M | 687.84M |
| SG&A Expenses | 451.62M | 462.29M | 473.74M | 460.34M | 450.41M |
| Depreciation & Amortization | 69.54M | 47.35M | 62.84M | 61.97M | 60.97M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 693.12M | 670.98M | 714.42M | 705.06M | 700.24M |
| Operating Income | 99.20M | 119.41M | 60.67M | 59.10M | 50.02M |
| Income Before Tax | 31.46M | -4.58M | -59.30M | -58.88M | -55.57M |
| Income Tax Expenses | 15.07M | 11.64M | -618.00K | -52.29M | -46.70M |
| Earnings from Continuing Operations | 16.39 | -16.22 | -58.68 | -6.59 | -8.87 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 16.39M | -16.22M | -58.68M | -6.59M | -8.87M |
| EBIT | 99.20M | 119.41M | 60.67M | 59.10M | 50.02M |
| EBITDA | 152.98M | 174.12M | 130.87M | 128.43M | 118.35M |
| EPS Basic | 0.04 | -0.04 | -0.14 | -0.02 | -0.02 |
| Normalized Basic EPS | 0.11 | 0.14 | 0.05 | 0.05 | 0.04 |
| EPS Diluted | 0.04 | -0.04 | -0.14 | -0.02 | -0.03 |
| Normalized Diluted EPS | 0.11 | 0.14 | 0.05 | 0.05 | 0.04 |
| Average Basic Shares Outstanding | 1.53B | 1.55B | 1.58B | 1.62B | 1.64B |
| Average Diluted Shares Outstanding | 1.55B | 1.57B | 1.59B | 1.62B | 1.64B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
